Results 141 to 150 of about 112,964 (206)

ABCC6 Transporter Contributed to Cisplatin Resistance on Bladder Cancer. [PDF]

Int J Med Sci
Chou KY, Chang AC, Hwang TI, Tsai TF, Ho CY, Liu HW, Achudhan D, Tang CH, Lin YY.   +8 more
europepmc   +1 more source

lncRNA <i>NAS1</i> Deficiency Drives Cisplatin Resistance via NR2F1-Mediated TGFB1/NF-κB Signaling Axis in NSCLC. [PDF]

Cancers (Basel)
Lin X, Wu Y, Wu Q, Tao W, Zhang J, Zhou J.   +5 more
europepmc   +1 more source

SLC25A10 promotes cisplatin resistance by inhibiting ferroptosis in cervical cancer. [PDF]

Cell Death Discov
Ma C, Lu X, Ni C, Gao Y, Yang F, Chen S, Du Y, Zhao F, Cao Y, Huang H.   +9 more
europepmc   +1 more source

miR-155-5p promotes osteosarcoma progression and cisplatin resistance by targeting the SOCS1/STAT1/c-Fos signaling axis. [PDF]

Discov Oncol
Lu J, Ren H, Song W, Xie S, Li X.
europepmc   +1 more source

Redox-triggered USP18 confers cisplatin resistance in ovarian cancer by selectively activating a non-canonical FSP1-dependent ferroptosis escape pathway. [PDF]

Redox Biol
Zhao Z, Ge G, Gong M, Liu Y, Ma L, Zhang D, Sun L, Song Y.   +7 more
europepmc   +1 more source

Key Nano-Strategies for Cisplatin Resistance in Advancing Anti-Cancer Therapy. [PDF]

Int J Nanomedicine
Lei SY, Qin H, Liu S, Sheng J.
europepmc   +1 more source

LINC00473 modulates protein expression to promote ovarian cancer progression and overcome cisplatin resistance. [PDF]

Oncol Lett
Zhang C, Ma J, Wang W, Guo M, Han C, Sadike M, Zhu K.   +6 more
europepmc   +1 more source

TRIM33 Reverses Cisplatin Resistance in Non-Small Cell Lung Cancer by Regulating the PI3K/AKT Pathway via Ubiquitination-Mediated Degradation of LPCAT1. [PDF]

World J Oncol
Huang J, Wang BQ, Wu Q, Wang LM, Guan C.
europepmc   +1 more source

HnRPD/AUF1 facilitates human ovarian cancer progression through activating FLI1 and maintaining cisplatin resistance. [PDF]

Mol Cancer
Tang C, Zhu C, An Z, Cao B, Xu Q, Li L, Bao Y, Li J.   +7 more
europepmc   +1 more source

<i>DNPEP</i> promotes the growth, metastasis, and cisplatin resistance of tongue squamous cell carcinoma through RACK1/ERK signaling pathway. [PDF]

Transl Cancer Res
Liu J, Xu Z, Xin Y, Jiang Q, Nie Z, Qiu J.   +5 more
europepmc   +1 more source